← SynDRA
NVP-TAE226
SynDRA canonical compound SYN0079251 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | IGF1R | PTK2 |
|---|
| Mechanism of action | protein tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- IGF1R INHIBITOR
- INSR INHIBITOR
- PTK2 INHIBITOR
- PTK2B INHIBITOR
- tyrosine kinase inhibitor
Cross-references
Synonyms
- RefChem:449665
- NVP TAE 226
- TAE226
- TAE226 (NVP-TAE226)
- TAE 226
- MFCD12031516
- CTx0152960
- CTx-0152960;CTx 0152960
- C23H25ClN6O3
- 2jkk
- UYJNQQDJUOUFQJ-UHFFFAOYSA-N
- BI9
- Kinome_1212
- MLS006011059
- NVP-TAE226?
- SCHEMBL375524
- GTPL9382
- orb1307113
- SCHEMBL29378728
- SCHEMBL29730430
- CHEBI:91452
- EX-A716
- GLXC-90111
- HMS3656L12
- HMS3672E03
- HMS3747C09
- BDBM50334594
- NSC787252
- s2820
- AKOS016004135
- CCG-269438
- CS-0594
- NSC-787252
- SB19397
- SDCCGSBI-0061740.P001
- NCGC00346931-01
- NCGC00346931-04
- NCGC00346931-05
- NCGC00346931-08
Look up NVP-TAE226 in the interactive SynDRA portal →